Improve ophthalmic surgery outcomes and patient compliance and reduce costs with compounded formulations from Imprimis Pharmaceuticals. Your surgeons can inject "Dropless" steroid-antibiotic combinations intraocularly after implanting the IOL, obviating the need for drops. Alternatively, give patients "LessDrops," a topical formulation with your choice of a combination of a steroid, a non-steroidal, and an antibiotic. Now a 503B FDA-registered outsourcing facility, Imprimis makes ordering easy. Expect a fast turnaround, no need for individual prescriptions and free shipping on all 503B orders.
Your product information request has been received and we will forward information to the contact information you provided shortly.